Showing 101 - 120 results of 1,014 for search 'development reprogramming', query time: 0.11s Refine Results
  1. 101

    Near-infrared light-driven metabolic reprogramming of synoviocytes for the treatment of rheumatoid arthritis by Hugang Zhang, Jiaxin Jia, Hanyu Liu, Haobo Han, Quanshun Li

    Published 2025-07-01
    “…The combination of APPC/pHO-1 and NIR can effectively reprogram the cellular metabolism and repolarize the macrophages and fibroblast-like synoviocytes, thereby inhibiting inflammation by suppressing glycolysis. …”
    Get full text
    Article
  2. 102
  3. 103

    NFIA-dependent upregulation of SMC4 promotes metastasis and metabolic reprogramming in glioma by Guoyin Li, Guoyin Li, Yukui Zhao, Yubo He, Zhaoqiang Qian, Xiaoyan Li, Zewen Song, Zhiqiang Liu

    Published 2025-08-01
    “…A prognostic model (SRRS) was developed via LASSO regression and validated across cohorts.ResultsSMC4 was significantly overexpressed in glioma tissues, with higher expression correlating with advanced tumor grades and poorer patient survival (AUC > 0.82). …”
    Get full text
    Article
  4. 104
  5. 105

    Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets by Zhiyang Yin, Guanlu Shen, Minjie Fan, Pengfei Zheng

    Published 2025-04-01
    “…However, challenges such as the complexity of drug development and metabolic interactions must be overcome. …”
    Get full text
    Article
  6. 106
  7. 107

    Metabolic reprogramming in hepatocellular carcinoma: an integrated omics study of lipid pathways and their diagnostic potential by Peng Dai, Jing Feng, Yanyan Dong, Shujing Zhang, Jianghong Cao, Xiaopeng Cui, Xueliang Qin, Shiming Yang, Daguang Fan

    Published 2025-06-01
    “…Abstract Metabolic reprogramming is an important cancer hallmark. Recent studies have indicated that lipid metabolic reprogramming play a potential role in the development of hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  8. 108

    Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy by Kun Huang, Ying Han, Yihong Chen, Hong Shen, Shan Zeng, Changjing Cai

    Published 2025-01-01
    “…These regulators provide a theoretical basis and research direction for the development of new strategies and targets in cancer therapy based on tumor metabolic reprogramming.…”
    Get full text
    Article
  9. 109

    Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling by Lixuan Wang, Weibo Jiang, Manshi Yang, Quezhu Danzeng, Shiyu Liu, Mengying Cui

    Published 2025-06-01
    “…Abstract Over the past decade, there has been a qualitative improvement in the understanding of gut microbiota in cancer development and treatment. Gut microbiota regulates metabolic reprogramming that occurs in the competition between tumor cells and immune cells for essential nutrients in the tumor microenvironment (TME). …”
    Get full text
    Article
  10. 110

    Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance by Lanyue Zhang, Jiangnan Zhao, Chunyu Su, Jianxi Wu, Lai Jiang, Hao Chi, Qin Wang

    Published 2025-03-01
    “…Metabolic reprogramming is a hallmark of ovarian cancer, enabling tumor progression, immune evasion and drug resistance. …”
    Get full text
    Article
  11. 111

    Coordination acid-engineered Prussian Blue affects glycometabolic reprogramming in microglia for epileptic treatment by Yao Zhao, Feixiang Chen, Chen Chen, Yuling Yang, Luo Wang, Jiaqi Zhu, Xin Wang, Yanyan Liu, Jing Ding

    Published 2025-06-01
    “…This study, utilizing single-nucleus RNA sequencing data from temporal lobe epilepsy (TLE) patients, reveals that reactive oxygen species (ROS) stabilize hypoxia-inducible factor 1-alpha (HIF-1α), thereby inducing glycometabolic reprogramming in microglia and driving the development of a pro-inflammatory phenotype. …”
    Get full text
    Article
  12. 112

    Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia by Jeremy B. Ducharme, Daria Neyroud, Martin M. Schonk, Miguel A. Gutierrez-Monreal, Zhiguang Huo, Haley O. Tucker, Karyn A. Esser, Sarah M. Judge, Andrew R. Judge

    Published 2025-05-01
    “…These findings thus implicate cancer/disease-specific functions of FOXP1 in the disruption and reprograming of the skeletal-muscle circadian transcriptome, which may contribute to muscle wasting and the development of cachexia.…”
    Get full text
    Article
  13. 113
  14. 114

    OASL enhances mRNA translation and reprograms lipid metabolism to promote cancer progression by Shi-Bing Li, Li Yuan, Qian-Ying Zhu, Gong Zhang, Yuan-Tao Liu, Ming-Hui Gao, Fei Han, Zhi-Rui Lin, Hua Zhang, Lin-Quan Tang, Li Sun, Qing-Yu He, Er-Wei Song, Lawrence S. Young, Yu-Chun Li, Hai-Qiang Mai, Mu-Sheng Zeng, Qian Zhong

    Published 2025-07-01
    “…Accumulating evidence suggests that persistent IFN-Is and a subset of IFN-stimulated genes (ISGs) might promote tumor development, but the regulation of mRNA translation and lipid metabolism during this process remains unknown. …”
    Get full text
    Article
  15. 115
  16. 116
  17. 117

    Mapping the landscape of metabolic reprogramming research in lung cancer: a bibliometric and visualized analysis by Song Han, Jialu Li, Feng Jiang, Qingtong Shi

    Published 2025-04-01
    “…Conclusions This bibliometric analysis maps the research landscape of metabolic reprogramming in lung cancer, identifying influential contributors and emerging research themes. …”
    Get full text
    Article
  18. 118
  19. 119

    Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming by Xi Zhang, Yue Liu, Yueyu Dai, Lingna An, Fangyuan Zhong, Shifeng Lou

    Published 2024-11-01
    “…Furthermore, we co-cultured AFA with CAR-T cells during the preparation stage and multianalyses of differentiation characteristics, metabolic profiling, and RNA sequencing revealed that AFA induce comprehensive metabolism remodeling and fate reprogramming. Based on it, we finally identified the antitumor efficacy of AFA-pretreatment CAR-T compared with negative-control CAR-T.Results We identified that AFA blocked the T-cell receptor (TCR) and phosphoinositide 3-kinase-protein kinase B-mechanistic target of rapamycin signaling pathways, induced metabolic reprogramming and modulated T-cell differentiation. …”
    Get full text
    Article
  20. 120

    Generation of bovine iPSCs from fetal fibroblasts for in vitro myogenesis and cultured meat by Kaiana Recchia, Methi Wathikthinnakon, Fabiana Fernandes Bressan, Fabiana Fernandes Bressan, Kristine Freude

    Published 2025-05-01
    “…Bovine induced pluripotent stem cells (biPSCs) represent a promising alternative due to their capacity for self-renewal and developmental plasticity.MethodsThis study utilized both lentiviral (integrating) and episomal (non-integrating) reprogramming strategies to generate biPSCs suitable for myogenic differentiation. …”
    Get full text
    Article